Shares of ProMetic Life Sciences Inc. (TSE:PLI – Get Free Report) shot up 0.2% on Monday . The stock traded as high as C$13.72 and last traded at C$13.60. 921 shares were traded during mid-day trading, a decline of 88% from the average session volume of 8,002 shares. The stock had previously closed at C$13.57.
ProMetic Life Sciences Stock Up 0.2 %
The company has a debt-to-equity ratio of 37.47, a current ratio of 4.06 and a quick ratio of 3.66. The business has a 50 day moving average price of C$13.60. The firm has a market capitalization of C$317.06 million and a P/E ratio of -0.22.
About ProMetic Life Sciences
Prometic Life Sciences Inc operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals.
See Also
- Five stocks we like better than ProMetic Life Sciences
- The How and Why of Investing in Gold Stocks
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- How to buy stock: A step-by-step guide for beginners
- 3 Value Stocks You Can Buy Before They Become Big
- 5 discounted opportunities for dividend growth investors
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for ProMetic Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProMetic Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
